(Q38571945)

4 September 2017

1 reference

title

Advantages and Disadvantages of Beta- Adrenergic Blocking Drugs in Hypertension (English)

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

26 March 2022

Advantages and disadvantages of beta-adrenergic blocking drugs in hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26299

Cardiology and cardiovascular medicine

26 March 2022

main subject

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

26 March 2022

author name string

E. T. O'Brien

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A26299

26 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=26299

26 March 2022

publication date

1 April 1978

1 reference

full work available at URL

4 September 2017

http://journals.sagepub.com/doi/pdf/10.1177/000331977802900410

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

26 March 2022

1 reference

4 September 2017

volume

29

1 reference

4 September 2017

issue

4

1 reference

4 September 2017

page(s)

332-336

1 reference

Role of blood pressure in cardiovascular morbidity and mortality

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Propranolol and polythiazide in treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Propranolol in the Treatment of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Medical intelligence drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Side Effects of Hypotensive Agents Evaluated by a Self-administered Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F000331977802900410

Total body potassium in long-term frusemide therapy: is potassium supplementation necessary?

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

Atenolol, methyldopa, and chlorthalidone in moderate hypertension

26 March 2022

8

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

Comparison of debrisoquine and guanethidine in treatment of hypertension

26 March 2022

12

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

Rebound phenomenon during gradual withdrawal of clonidine

26 March 2022

13

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

Hypertension and Compliance: Implications for the Primary Physician

26 March 2022

15

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

Editorial: Beta-blockers in anxiety and stress

26 March 2022

18

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

Blood pressure and heart rate and withdrawal of antihypertensive drugs

26 March 2022

21

1 reference

https://api.crossref.org/works/10.1177/000331977802900410

26 March 2022

Identifiers

0 references

1 reference